Chimeric Antigen Receptor (CAR)-T Immunotherapies Monitoring Program       See Table 75

Please see the links below for a description of the Chimeric Antigen Receptor (CAR)-T Monitoring Program, including medications and requirements for reporting member outcomes. The link to Table 75 above can be used for more information on PA requirements and evaluation criteria.

Chimeric Antigen Receptor (CAR)-T Immunotherapies Monitoring Program PDF DOC  |  PDF

  

Pediatric Behavioral Health Medication Initiative       See Table 71

Please see the links below for a description of the Pediatric Behavioral Health Medication Initiative (PBHMI), including a medication list and situations that require prior authorization (PA) for members < 18 years of age. The link to Table 71 above can be used for more information on PA requirements and evaluation criteria.

Pediatric Behavioral Health Medication Initiative PDF DOC  |  PDF

Please see the following link to find out more information about the Pediatric Behavioral Health Medication Initiative (e.g., Letter to Prescribers).

https://www.mass.gov/info-details/pediatric-behavioral-health-medication-initiative-pbhmi-information

 

Hepatitis C Virus Clinical Information       See Table 44

Please see the links below for more clinical information on the use of direct-acting antivirals for Hepatitis C. The link to Table 44 above can be used for more information on the PA status of the agents on the MassHealth Drug List.

Hepatitis C Virus Clinical Information PDF DOC  |  PDF

   

Opioid and Pain Initiative       See Table 8

Please see the following link to find more Opioids and Controlled Substances Information (e.g., Letter to Prescribers).

https://www.mass.gov/lists/opioids-and-controlled-substances-information

Opioid and Pain Initiative PDF DOC  |  PDF

  

Second-Generation (Atypical) Antipsychotic Initiative   See Table 24

Please see the following link to find out more information about second-generation (atypical) antipsychotics (e.g., Letter to Prescribers).

https://www.mass.gov/lists/second-generation-antipsychotics-also-known-as-atypical-antipsychotics